Literature DB >> 10326547

Prostate-specific membrane antigen expression in the duodenum: implications in coeliac disease and immunotherapy for prostate cancer.

B H Maraj, M A Aldersley, A F Markham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10326547     DOI: 10.1016/s0140-6736(05)61125-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.

Authors:  Chao Zeng; Zun-Fu Ke; Zheng Yang; Zhuo Wang; Shi-Cong Yang; Can-Qiao Luo; Lian-Tang Wang
Journal:  Med Oncol       Date:  2011-10-19       Impact factor: 3.064

2.  Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.

Authors:  Andreas Delker; Wolfgang Peter Fendler; Clemens Kratochwil; Anika Brunegraf; Astrid Gosewisch; Franz Josef Gildehaus; Stefan Tritschler; Christian Georg Stief; Klaus Kopka; Uwe Haberkorn; Peter Bartenstein; Guido Böning
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-29       Impact factor: 9.236

3.  Improvement in Therapeutic Efficacy and Reduction in Cellular Toxicity: Introduction of a Novel Anti-PSMA-Conjugated Hybrid Antiandrogen Nanoparticle.

Authors:  Chellappagounder Thangavel; Maryna Perepelyuk; Ettickan Boopathi; Yi Liu; Steven Polischak; Deepak A Deshpande; Khadija Rafiq; Adam P Dicker; Karen E Knudsen; Sunday A Shoyele; Robert B Den
Journal:  Mol Pharm       Date:  2018-04-04       Impact factor: 4.939

4.  PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

Authors:  A Afshar-Oromieh; A Malcher; M Eder; M Eisenhut; H G Linhart; B A Hadaschik; T Holland-Letz; F L Giesel; C Kratochwil; S Haufe; U Haberkorn; C M Zechmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-24       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.